The outcome of a study done by Dr. James Forsythe showed that Poly-MVA is a safe (both orally/IV) and extremely effective supplement for support and palliative assistance in stage IV cancer patients, either with or without concomitant chemotherapy. The safety profile is excellent and there were no treatment related deaths or any significant adverse reactions or negative interactions with chemotherapy or hormonal treatments. The best responding tumors were: Prostate, Breast, Lung, Head/Neck, Colorectal, and Hematological. Results show an improved Overall Response Rate over historical controls. Other research has shown a benefit for neurological diseases such as Parkinson’s, Alzheimer’s and Huntington’s.